EQUAL CPA Score 2022: a tool to measure guideline adherence for chronic pulmonary aspergillosis.
Rosanne SpruteEva Van BraeckelHolger FlickMartin HoeniglChris KosmidisRitesh AgarwalJesper Rømhild DavidsenChristian Borbjerg LaursenOliver Andreas CornelyDanila SeidelPublished in: The Journal of antimicrobial chemotherapy (2022)
The EQUAL CPA Score intents to be used as a comprehensive tool for measuring guideline adherence. If adherence to current guidelines is associated with clinical outcome, this will be assessed in future studies.